BBT002

DRUG3 trials

Sponsors

Bambusa Therapeutics

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Phase 1

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

RecruitingNCT06944925

Bambusa TherapeuticsChronic Obstructive Pulmonary Disease

Start: 2025-05-08End: 2027-07-31Target: 286Updated: 2026-07-01

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)

RecruitingNCT07288554

Bambusa TherapeuticsChronic Obstructive Pulmonary Disease (COPD)

Start: 2025-09-05End: 2027-05-30Target: 68Updated: 2026-07-22

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma

RecruitingNCT07436949

Bambusa TherapeuticsChronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Start: 2026-03-02End: 2028-06-30Target: 64Updated: 2026-07-22